Logo

Gland Pharma Share Price

Gland Pharma (INR)184231.9   (1.8%)

Exchange ScripsBSE543245NSEGLANDISININE068V01023

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Gland Pharma Performance

Market performance
Open price1810.7
High1851.95
Volumes358717
Prev Close1842
Low1810.7
Closing date2025-01-02
Historical performance
1 Year High2220.95
3 Year High4062.95
5 Year High4350.00
1 Year Low1585.70
3 Year Low861.00
5 Year Low861.00

Gland Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
30361
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
39.28
Dividend Yield
Dividend Yield
1.09 %

Gland Pharma Investment Returns

1 Year
-6.8%
3 Years
-52.3%
5 Years
N/A
10 Years
N/A

Gland Pharma Technicals

IndicatorsValueSignal
5-DMA1805.32Bullish
10-DMA1794.51Bullish
20-DMA1784.7Bullish
50-DMA1750.38Bullish
100-DMA1791.7Bullish
200-DMA1820.11Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters55555
Foreign Investors55555
Domestic Investors---------------
Public Investors122353122660122370136016161622
Government---------------

Gland Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1702240522391348
Operating Profit15033126521734114370
Interest262745234
Depreciation344614671103988
Profit Before Tax11325105461618613348
Consolidated Net Profit77257810121179970
Adjusted EPS47477461

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital165165164164
Total Reserves87060794067128058615
Minority Interest------------
Total Non-Current Liabilities4886897940803
Total Liabilities106108877757833664961
Capital Work in Progress2379177218073378
Total Assets106108877757833664961

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities9968364079086049
Cash Flow from Investing Activities-1756912082-10026-15240
Cash Flow from Financing Activitie-799414934912385
Net Cash Inflow / Outflow-1559515871-17703194
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 39.28.
  • 3Y Stock Price CAGR of the stock is -21.8.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹15033 Million.
  • The company generated revenue of ₹56647 Million in the previous financial year.

Gland Pharma

184231.9   (1.8%)

Investment Amount: ₹ 203110
Current Value: ₹ 184200
Performance: -9.3%
P/L: ₹ -18910
Top Gainers
SymbolChange%
RICOAUTO99.23(20%)
AMNPLST330.7(18%)
SUNDARMFIN4698.9(15%)
TRANSRAILL642.9(14%)
RIIL1207.75(11%)
Top Losers
SymbolChange%
JAICORPLTD248.4(-20%)
WEL155.86(-6%)
PETRONET327.75(-6%)
FILATFASH0.69(-6%)
3IINFOLTD31.89(-5%)
MIRCELECTR24.97(-5%)
PDMJEPAPER187.1(-5%)
HOVS81.22(-5%)
Similar stocks

Bajaj Healthcare

54.6

609.35

December 2 - January 2

Ind-Swift

47.6

31.58

December 2 - January 2

Brooks Laboratories

35.8

187.41

December 2 - January 2

Lincoln Pharma

33

846.1

December 2 - January 2

Zota Health Care

31.9

802.45

December 2 - January 2

Ind-Swift Lab.

23.5

111.05

December 2 - January 2

Lasa Supergenerics

20.2

29.7

December 2 - January 2

Medico Remedies

20.1

57.36

December 2 - January 2

Announcing Stock of the Month!

Stock of the Month
Stock of the Month